MDCG Position Paper | Notice to manufacturers and notified bodies to ensure timely compliance with MDR and IVDR requirements

January 3, 2024

The Medical Device Coordination Group (MDCG) of the European Commission issued a position paper urgently calling manufacturers to transition to the Regulations and submit their application for their medical devices certification without further delay.

With the adoption of Regulations (EU) 2017/745 (MDR) and 2017/746 (IVDR), the regulatory framework for medical devices and in vitro diagnostic medical devices (IVD) has significantly changed.

However, data provided by notified bodies shows limited progress in terms of applications submitted and certificates issued, being the situation even more worrisome for IVDs. While only around 8% of IVDs required notified body involvement for conformity assessment under Directive 98/79/EC on in vitro diagnostic medical devices (IVDD), this proportion is around 80% under the IVDR.

Manufacturers should keep in mind that the duration of the conformity assessment process once the application is submitted to a notified body currently takes longer than under the former directives. Notified body data reveals that a significant number of manufacturers’ applications are incomplete, potentially causing delays in the certification process. Given the established deadlines by the Regulations, manufacturers are strongly advised to intensify their efforts for an early transition and avoid further submission delays, as this could result in bottlenecks in notified body workflows and potential shortages of products in the market.

Need help? We can assist in getting your medical devices certified under MDR and IVDR. Contact us asap!

Send us an email: medtech@asphalion.com

Or schedule a free 30-minute meeting here: SCHEDULE A FREE MEETING HERE

Search News & Events

  • Filter by category

Share

Related news and events

NEWS | New Insight on the Implementation of MDR Article 17

Article 17 of Regulation (EU) 2017/745 (Medical Device Regulation – MDR) regulates the reprocessing of single-use devices (SUDs) with relevance for the European Economic Area (EEA) which may only take place where permitted by national law and in accordance with this article.

The European Union’s AI Act & its Impact on Medical Devices

The AI Act (AIA) is the EU’s first attempt to create a comprehensive AI regulatory framework and aims to ensure the protection of fundamental rights in this field. AI applications used in healthcare are often ‘medical devices’ and are thus regulated under the EU Medical Devices Regulation (MDR).

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting